Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14365/5234
Title: Resting state electroencephalographic alpha rhythms are sensitive to Alzheimer's disease mild cognitive impairment progression at a 6-month follow-up
Authors: Babiloni, C.
Jakhar, D.
Tucci, F.
Del, Percio, C.
Lopez, S.
Soricelli, A.
Salvatore, M.
Yener, Görsev
Keywords: Alzheimer's disease progression
Exact Low-resolution Brain Electromagnetic Source Tomography (eLORETA)
Mild cognitive impairment due to Alzheimer's disease (ADMCI)
Resting state electroencephalographic (rsEEG) rhythms
biological marker
biological marker
aged
alpha rhythm
Alzheimer disease
arousal
Article
controlled study
disease exacerbation
electroencephalogram
female
follow up
human
major clinical study
male
mild cognitive impairment
neuroimaging
resting state network
wakefulness
alpha rhythm
brain cortex
cognitive defect
diagnostic imaging
electroencephalography
procedures
psychology
rest
Alpha Rhythm
Alzheimer Disease
Biomarkers
Cerebral Cortex
Cognitive Dysfunction
Electroencephalography
Follow-Up Studies
Humans
Rest
Publisher: Elsevier Inc.
Abstract: Are posterior resting-state electroencephalographic (rsEEG) alpha rhythms sensitive to the Alzheimer's disease mild cognitive impairment (ADMCI) progression at a 6-month follow-up? Clinical, cerebrospinal, neuroimaging, and rsEEG datasets in 52 ADMCI and 60 Healthy old seniors (equivalent groups for demographic features) were available from an international archive (www.pdwaves.eu). The ADMCI patients were arbitrarily divided into two groups: REACTIVE and UNREACTIVE, based on the reduction (reactivity) in the posterior rsEEG alpha eLORETA source activities from the eyes-closed to eyes-open condition at ≥ −10% and −10%, respectively. 75% of the ADMCI patients were REACTIVE. Compared to the UNREACTIVE group, the REACTIVE group showed (1) less abnormal posterior rsEEG source activity during the eyes-closed condition and (2) a decrease in that activity at the 6-month follow-up. These effects could not be explained by neuroimaging and neuropsychological biomarkers of AD. Such a biomarker might reflect abnormalities in cortical arousal in quiet wakefulness to be used for clinical studies in ADMCI patients using 6-month follow-ups. © 2024 The Authors
URI: https://doi.org/10.1016/j.neurobiolaging.2024.01.013
https://hdl.handle.net/20.500.14365/5234
ISSN: 0197-4580
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Files in This Item:
File SizeFormat 
5234.pdf8.52 MBAdobe PDFView/Open
Show full item record



CORE Recommender

SCOPUSTM   
Citations

4
checked on Nov 20, 2024

WEB OF SCIENCETM
Citations

3
checked on Nov 20, 2024

Page view(s)

72
checked on Nov 18, 2024

Download(s)

46
checked on Nov 18, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.